JP2013542960A5 - - Google Patents

Download PDF

Info

Publication number
JP2013542960A5
JP2013542960A5 JP2013537904A JP2013537904A JP2013542960A5 JP 2013542960 A5 JP2013542960 A5 JP 2013542960A5 JP 2013537904 A JP2013537904 A JP 2013537904A JP 2013537904 A JP2013537904 A JP 2013537904A JP 2013542960 A5 JP2013542960 A5 JP 2013542960A5
Authority
JP
Japan
Prior art keywords
phenyl
sulfonyl
diazaspiro
oxa
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013537904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013542960A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/059563 external-priority patent/WO2012064642A1/en
Publication of JP2013542960A publication Critical patent/JP2013542960A/ja
Publication of JP2013542960A5 publication Critical patent/JP2013542960A5/ja
Pending legal-status Critical Current

Links

JP2013537904A 2010-11-08 2011-11-07 脂肪酸シンターゼ阻害剤 Pending JP2013542960A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41111010P 2010-11-08 2010-11-08
US61/411,110 2010-11-08
PCT/US2011/059563 WO2012064642A1 (en) 2010-11-08 2011-11-07 Fatty acid synthase inhibitors

Publications (2)

Publication Number Publication Date
JP2013542960A JP2013542960A (ja) 2013-11-28
JP2013542960A5 true JP2013542960A5 (https=) 2014-10-23

Family

ID=46051253

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013537904A Pending JP2013542960A (ja) 2010-11-08 2011-11-07 脂肪酸シンターゼ阻害剤

Country Status (4)

Country Link
US (1) US20130237535A1 (https=)
EP (1) EP2637660A4 (https=)
JP (1) JP2013542960A (https=)
WO (1) WO2012064642A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5964426B2 (ja) * 2011-08-19 2016-08-03 グラクソスミスクライン、インテレクチュアル、プロパティー、ナンバー2、リミテッドGlaxosmithkline Intellectual Property No.2 Limited 脂肪酸シンターゼ阻害剤
WO2013177253A2 (en) * 2012-05-22 2013-11-28 Glaxosmithkline Llc Fatty acid synthase inhibitors
AR092211A1 (es) 2012-09-24 2015-04-08 Merck Patent Ges Mit Beschränkter Haftung Derivados de hidropirrolopirrol
ES2651331T3 (es) 2013-01-10 2018-01-25 Glaxosmithkline Intellectual Property (No. 2) Limited Inhibidores de la sintasa de ácidos grasos
SG10201707409PA (en) 2013-03-13 2017-10-30 Forma Therapeutics Inc Novel compounds and compositions for inhibition of fasn
ES2849951T3 (es) 2015-06-18 2021-08-24 89Bio Ltd Derivados de piperidina 4-bencil y 4-benzoil sustituidos
EA201890086A1 (ru) 2015-06-18 2018-06-29 Сефалон, Инк. 1,4-замещенные производные пиперидина
JP7007374B2 (ja) 2016-09-23 2022-01-24 ノバルティス アーゲー 腱及び/又は靭帯損傷に使用するためのインダゾール化合物
JOP20190053A1 (ar) 2016-09-23 2019-03-21 Novartis Ag مركبات أزا إندازول للاستخدام في إصابات الأوتار و/ أو الرباط
CN107628968B (zh) * 2017-10-10 2019-09-06 北京汇康博源医药科技有限公司 一种简便合成1-氨基-1-腈基-环丙烷的方法
CN112154561B (zh) 2018-05-30 2025-10-14 罗伯特·博世有限公司 包括具有由支撑框架支撑的边缘绝缘装置的双极电池单元的电池
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
US10793554B2 (en) 2018-10-29 2020-10-06 Forma Therapeutics, Inc. Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone
CN114286676A (zh) * 2019-08-22 2022-04-05 密歇根大学董事会 治疗kras相关癌症的方法
CN111574414A (zh) * 2020-05-20 2020-08-25 上海毕得医药科技有限公司 一种4-溴-2-甲氧基苯磺酰氯的合成方法
US20250084062A1 (en) * 2021-12-27 2025-03-13 Astellas Pharma Inc. Substituted quinoline derivative
CN116478158A (zh) * 2023-04-26 2023-07-25 湖南警察学院 一种制备螺环化合物的方法
US20250375429A1 (en) 2024-05-29 2025-12-11 Smarter Not Harder, Inc. Obligate pairing of orthosteric and non-orthosteric gaba ligands in pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69633245T2 (de) * 1995-09-29 2005-09-08 Eli Lilly And Co., Indianapolis Spiroverbindungen als Inhibitoren der Fibrinogen-abhängigen Blutplättchenaggregation
CO5180605A1 (es) * 1999-06-23 2002-07-30 Smithkline Beecham Corp Compuestos de indol
ATE250604T1 (de) * 1999-10-27 2003-10-15 Millennium Pharm Inc Pyridyl enthaltende spirocyclische verbindungen als inhibitoren der fibrinogen-abhängigen blutplättchen aggregation
US7498323B2 (en) * 2003-04-18 2009-03-03 Ono Pharmaceuticals Co., Ltd. Spiro-piperidine compounds and medicinal use thereof
WO2006006490A1 (ja) * 2004-07-08 2006-01-19 Ono Pharmaceutical Co., Ltd. スピロ化合物
TW200831092A (en) * 2006-12-21 2008-08-01 Astrazeneca Ab Therapeutic agents
WO2008088692A2 (en) * 2007-01-12 2008-07-24 Merck & Co., Inc. Spirochromanon derivatives
CN101835779B (zh) * 2007-10-26 2014-01-29 霍夫曼-拉罗奇有限公司 作为pi3激酶抑制剂的嘌呤衍生物
US8450350B2 (en) * 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase

Similar Documents

Publication Publication Date Title
JP2013542960A5 (https=)
JP2012512888A5 (https=)
TWI641595B (zh) 氰基三唑化合物類
RU2018123779A (ru) Новые соединения
JP5345140B2 (ja) プロトンポンプ阻害剤としての5員複素環化合物
JP2014521748A5 (https=)
JP2007509141A5 (https=)
CA2459224C (en) 1,3-benzothiazinone derivatives and the use thereof
JP2013507425A5 (https=)
JP2012532931A5 (https=)
JP2010524942A5 (https=)
JP2017505762A5 (https=)
ES2361933T3 (es) Uso de derivados de azabiciclo hexano.
RU2012126083A (ru) Производные аминооксазина
ME02104B (me) Inhibitori kinaza koji regulisu signalne puteve u apoptozi
AU2011346567A1 (en) Bi-heteroaryl compounds as Vps34 inhibitors
CA2772920C (en) Thiazoles derivatives for treating or preventing mood disorders
JP2014520885A5 (https=)
JP2013534245A5 (https=)
RU2013134334A (ru) Хиноксалины и азахиноксалины в качестве модуляторов рецептора crth2
WO2012064642A1 (en) Fatty acid synthase inhibitors
CN114748622A (zh) P38激酶抑制剂降低dux4和下游基因表达以用于治疗fshd
JP2016501185A5 (https=)
JP2017501237A5 (https=)
JP2012522766A5 (https=)